Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

WIN 2019 Symposium /
Integration of DNA and RNA investigations in clinical trials: A laboratory challenge

23rd - 24th Jun 2019

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 10.07.19
Views: 224

Brandon Young - Bowden WIN Precision Oncology Laboratory, Murrieta, USA

Brandon Young speaks to ecancer at the WIN 2019 Symposium in Paris about how the integration of DNA and RNA investigations in clinical trials.

He gives background and findings from the triple combination SPRING trial for patients with non-small cell lung cancer.

He explains that there are six different triple combinations that they are interested in studying and that they would like to use the Sims algorithm in order to utilise the full expression profile.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation